Motley Fool Live, Feb. 8, Fool.com contributors Brian Orelli and Keith Speights go over the claims. They also go over the company's response to the short attacks and whether these reports from shorts are really helpful for investors. Brian Orelli: Moving onto Clover Health Investments. They came under a short attack by the aptly named Hindenburg Research last week, we should probably start off the conversation by saying that Clover is a Fool recommendation and neither one of us is part of the teams that picked the company, although we've both written articles about it for Fool.com or the premium recommendations. We have a pretty good understanding of the company and what's going on here. Do you want to go through Hindenburg's main allegations and then I will take the company responding -- I'll take those?